Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what steps his Department has taken to ensure that the Meningococcal B vaccine is available as appropriate to children in all parts of the country.
Immunisation to protect against meningococcal disease capsular group B (MenB) has been routinely offered to all infants nationwide since 1 September 2015. This remains the case and there are currently no issues affecting the delivery of this immunisation. Preliminary estimates of MenB vaccine uptake indicate that over 95% of infants received at least one dose of vaccine by 26 weeks of age. A wide range of leaflets and online information have been produced to publicise this important immunisation.